Company CARMAT

Equities

ALCAR

FR0010907956

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Ratings for CARMAT

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Devices & Implants

Market Closed - Euronext Paris Other stock markets 11:35:14 2024-05-31 am EDT			5-day change	1st Jan Change
3.15 ^EUR	-.--%		+5.00%	-52.99%

May. 21	CARMAT : Invest Securities remains Buy, lowers its target	CF
May. 17	Oddo BHF Cuts Carmat PT, Affirms Neutral Rating	MT

CARMAT specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnostics system. The artificial heart is intended for patients with advanced cardiac insufficiency who are ineligible for a transplant and have exhausted all medication alternatives.

Number of employees: 182

EUR in Million	2022	Weight	2023	Weight	Delta
Orthotropic and Biocompatible Artificial Heart 100.0 %	0	100.0 %	3	100.0 %	+710.72%

EUR in Million	2022	Weight	2023	Weight	Delta
France 100.0 %	0	100.0 %	3	100.0 %	+710.72%

Managers	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	53	16-08-31
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	18-12-11
Marc Grimmé CTO	Chief Tech/Sci/R&D Officer	-	08-06-24
Piet Jansen CTO	Chief Tech/Sci/R&D Officer	65	09-11-30
Alexandre Eleonore PRN	Corporate Officer/Principal	-	-
Thierry Dupoux PRN	Corporate Officer/Principal	-	18-07-29
Christian Latrémouille PRN	Corporate Officer/Principal	-	21-01-30
Raouia Bouyanzer HRO	Human Resources Officer	-	11-01-31
Francesco Arecchi PRN	Corporate Officer/Principal	-	17-08-31

Members of the board	Title	Age	Since
Alexandre Conroy CHM	Chairman	61	22-12-21
Pierre Bastid BRD	Director/Board Member	69	18-04-04
Florent Battistella BRD	Director/Board Member	61	21-05-06
André Muller BRD	Director/Board Member	60	19-12-31
Michael Mack BRD	Director/Board Member	77	17-04-19
Stéphane Piat CEO	Chief Executive Officer	53	16-08-31
Jean-Luc Lemercier BRD	Director/Board Member	66	17-01-01
David Coti BRD	Director/Board Member	39	21-05-06
John Hernandez BRD	Director/Board Member	57	21-05-06

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	24,749,788	23,143,669 ( 93.51 %)	9,477 ( 0.0383 %)	93.51 %

Name	Equities	%	Valuation
AIRBUS SE 9.169 %	2,670,640	9.169 %	9 M €
Pierre Bastid 6.542 %	1,905,288	6.542 %	6 M €
Antonino Ligresti 6.262 %	1,823,900	6.262 %	6 M €
Gaspard Family 3.100 %	903,000	3.100 %	3 M €
Alain Carpentier 2.100 %	611,583	2.100 %	2 M €
Cornovum SASU 1.575 %	458,715	1.575 %	1 M €
OFI Invest Asset Management SA 0.7553 %	220,000	0.7553 %	708 057 €
La Française Asset Management SAS 0.6867 %	200,000	0.6867 %	643 688 €
Apo Asset Management GmbH 0.2266 %	66,000	0.2266 %	212 417 €
Groupe des Assurances du Crédit Mutuel SA 0.1381 %	40,224	0.1381 %	129 459 €

Name	Equities	%	Valuation
CARMAT 0.03%	8,103	0.03%	26,079 $

Carmat SA

36, avenue de l'Europe Immeuble l'Etendard Energy III

78140, Vélizy-Villacoublay

+33 1 39 45 64 50

http://www.carmatsa.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.15 EUR

Average target price

12.32 EUR

Spread / Average Target

+291.27%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Medical Devices & Implants

	1st Jan change	Capi.
CARMAT	-52.99%	118M
STRYKER CORPORATION	+13.73%	130B
SMITH & NEPHEW PLC	-8.17%	10.99B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-4.33%	8.35B
GLAUKOS CORPORATION	+41.80%	5.67B
INSPIRE MEDICAL SYSTEMS, INC.	-21.94%	4.72B
AXONICS, INC.	+7.81%	3.42B
ENOVIS CORPORATION	-10.26%	2.76B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-10.29%	2.11B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-13.58%	1.92B

Medical Devices & Implants